切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2017, Vol. 11 ›› Issue (11) : 1889 -1893. doi: 10.3877/cma.j.issn.1674-0785.2017.11.006

所属专题: 文献

基础论著

小剂量氢化可的松与血必净对急性肺损伤大鼠作用比较
郭琳瑛1, 李红日2, 张琪1,(), 崔小岱3, 宋国维1   
  1. 1. 100020 北京,首都儿科研究所附属儿童医院重症医学科
    2. 100020 北京京都儿童医院重症医学科
    3. 100020 北京京都儿童医院中心试验室
  • 收稿日期:2017-03-21 出版日期:2017-06-01
  • 通信作者: 张琪

Comparison of the effects of low-dose hydrocortisone and Xuebijing injection on acute lung injury in rats

Linying Guo1, Hongri Li2, Qi Zhang1,(), Xiaodai Cui3, Guowei Song1   

  1. 1. Department of Critical Care Medicine, Children′s Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China
    2. Department of Critical Care Medicine, Beijing Jingdu Children′s Hospital, Beijing 102208, China
    3. Department of Central Clinical Laboratory, Children′s Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China
  • Received:2017-03-21 Published:2017-06-01
  • Corresponding author: Qi Zhang
  • About author:
    Corresponding author: Zhang Qi, Email:
引用本文:

郭琳瑛, 李红日, 张琪, 崔小岱, 宋国维. 小剂量氢化可的松与血必净对急性肺损伤大鼠作用比较[J]. 中华临床医师杂志(电子版), 2017, 11(11): 1889-1893.

Linying Guo, Hongri Li, Qi Zhang, Xiaodai Cui, Guowei Song. Comparison of the effects of low-dose hydrocortisone and Xuebijing injection on acute lung injury in rats[J]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(11): 1889-1893.

目的

观察小剂量氢化可的松与血必净注射液对大肠埃希菌导致的大鼠急性肺损伤(ALI)的保护作用。

方法

大肠埃希菌[O111B4,(4.4~5.6)×1012CFU/L]3 ml/kg气管注射制作大鼠肺内源性ALI模型,设氢化可的松干预组[HC组,腹腔注射氢化可的松5 mg/(kg?d),共2天]、血必净干预组[X组,腹腔注射血必净注射液5 ml/(kg?d),共2 d]、模型对照组[C组,腹腔注射生理盐水5 ml/(kg?d),共2天]、正常对照组[N组,气管注射3 ml/(kg?d)生理盐水,腹腔注射生理盐水5 ml/(kg?d),共2天]。各组分别于末次给药后12 h放血处死动物,留血清测TNF-α、IL-8水平。取左肺计算肺指数。

结果

(1)HC组、X组、C组病死率无统计学意义(χ2=0.194,P=1.000);(2)TNF-α水平:HC组及X组[分别为(80.31±11.87)ng/L,(89.42±22.76)ng/L]均明显低于C组[(125.68±27.91)ng/L](P<0.05),HC组与X组差别无统计学意义(P>0.05);(3)IL-8水平:HC组与X组[分别为(175.01±40.29)ng/L,(214.38±56.03)ng/L]均明显低于C组[(266.48± 56.09)ng/L](P<0.05),HC组与X组差别无统计学意义(P>0.05);(4)肺指数:HC组与X组[分别为(0.318±0.058)%,(0.352±0.046)%]均明显低于C组[(0.412±0.055)%](P<0.05),HC组与X组差别无统计学意义(P>0.05)。

结论

小剂量氢化可的松及血必净治疗大肠杆菌导致的大鼠ALI均能明显降低血清促炎因子的水平,减轻肺水肿,两者作用相似。

Objective

To investigate the efficacy of low-dose hydrocortisone and Xuebijing injection on acute lung injury (ALI) induced by Escherichia coli (E.coli) in rats.

Methods

ALI model was induced in Wistar rats by intratracheal E.coli injection [3 ml/kg, O111B4, (4.4~5.6)×1012CFU/L], twelve hours later the survived rats were randomly divided into hydrocortisone group (HC) treated with hydrocortisone for two days [5 mg/(kg?d), intraperitoneally], Xuebijing group (X) treated with Xuebijing injection for two days [5 ml/(kg?d), intraperitoneally], and ALI control group (C) treated with normal saline for two days (5 ml/(kg?d), intraperitoneally). And there was a normal control group (N) that received intratracheal E.coli (3 ml/kg) injection and was treated with intraperitoneal normal saline for two days [5 ml/(kg?d)]. Twelve hours after the treatment the rats were killed, and the levels of TNF- and IL-8 in serum were measured by ELASA, then the lung index was calculated.

Results

There was no difference in mortality among group HC, X and C (χ2=0.194, P=1.000). The levels of TNF- in serum in group HC and X [(80.31±11.87) ng/L and (89.42±22.76) ng/L, respectively] were significantly lower than that in group C [(125.68±27.91) ng/L] (P<0.05), but there was no significant difference between group HC and X (P>0.05); IL-8 in group HC and X [(175.01±40.29) ng/L and (214.38±56.03) ng/L, respectively] were significantly lower than that in group C [(266.48±56.09) ng/L] (P<0.05), but there was no significant difference between group HC and X (P>0.05); The lung index in group HC and X [(0.318±0.058)% and (0.352±0.046)%, respectively] were significantly lower than that in group C [(0.412±0.055)%] (P<0.05), but there was no significant difference between group HC and X (P>0.05).

Conclusion

Both low-dose hydrocortisone and Xuebijing injection can inhibit the production of pro-inflammatory cytokines and attenuate pulmonary edema in rats with E.coli-induced ALI with similar effects.

表1 血清中TNF-α、IL-8及肺指数的变化(±s
[1]
Erickson S, Schibler A, Numa A, et al. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study [J]. Pediatr Crit Care Med, 2007, 8(4): 317-323.
[2]
李红日,宋国维,甘小庄, 等. 内源性急性肺损伤大鼠模型的建立 [J]. 中国小儿急救医学, 2010, 17(1): 40-42.
[3]
喻文亮,陆铸今,王莹, 等. 小儿急性呼吸窘迫综合征前瞻性多中心临床流行病学研究 [J]. 中华急诊医学杂志, 2005, 14(6): 448-453.
[4]
Cheifetz IM. Pediatric acute respiratory distress syndrome [J]. Respir Care, 2011, 56(10): 1589-1599.
[5]
DiBlasi RM, Cheifetz IM. Neonatal and pediatric respiratory care: what does the future hold? [J]. Respir Care, 2011, 56(9): 1466-1480.
[6]
Raghavendran K, Willson D, Notter RH. Surfactant therapy for acute lung injury and acute respiratory distress syndrome [J]. Crit Care Clin, 2011, 27(3): 525-559.
[7]
Puntorieri V, Hiansen JQ, McCaig LA, et al. The effects of exogenous surfactant administration on ventilation-induced inflammation in mouse models of lunginjury [J]. BMC Pulm Med, 2013, 13: 67.
[8]
Fuller BM, Mohr NM, Dettmer M, et al. Mechanical ventilation and acute lung injury in emergency department patients with severe sepsis and septic shock: an observational study [J]. Acad Emerg Med, 2013, 20(7): 659-669.
[9]
Ried M, Bein T, Philipp A, et al. Extracorporeal lung support in trauma patients with severe chest injury and acute lung failure: a 10-year institutional experience [J]. Crit Care, 2013, 17(3): R110.
[10]
Hodgson CL, Tuxen DV, Davies AR, et al. A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome [J]. Crit Care, 2011, 15(3): R133.
[11]
Ware LB, Koyama T, Zhao Z, et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome [J]. Crit Care, 2013, 17(5): R253.
[12]
Hall MW, Geyer SM, Guo CY, et al. Innate immune function and mortality in critically ill children with influenza: a multicenter study [J]. Crit Care Med, 2013, 41(1): 224-236.
[13]
Bouros D, Alexandrakis MG, Antoniou KM, et al. The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Acute Respiratory Distress Syndrome [J]. BMC Pulm Med, 2004, 4(6): 1-9.
[14]
Ware LB. Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design [J]. Crit Care Med, 2005, 33(3): S217-222.
[15]
Hagau N, Slavcovici A, Gonganau DN, et al. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection [J]. Crit Care, 2010, 14(6): R203.
[16]
Yang G, Hamacher J, Gorshkov B, et al. The Dual Role of TNF in Pulmonary Edema [J]. J Cardiovasc Dis Res, 2010, 1(1): 29-36.
[17]
Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNFalpha in pulmonary pathophysiology [J]. Respir Res, 2006, 7: 125.
[18]
Kambas K, Markiewski MM, Pneumatikos IA, et al. C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome [J]. J Immunol, 2008, 180(11): 7368-7375.
[19]
Ware LB, Koyama T, Billheimer DD, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury [J]. Chest, 2010, 137(2): 288-296.
[20]
Qazi BS, Tang K, Qazi A. Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis [J]. Int J Inflam, 2011, 2011: 908468.
[21]
Samransamruajkit R, Jiraratanawong K, Siritantiwat S, et al. Potent inflammatory cytokine response following lung volume recruitment maneuvers with HFOV in pediatric acute respiratory distress syndrome [J]. Asian Pac J Allergy Immunol, 2012, 30(3): 197-203.
[22]
de Pablo R, Monserrat J, Prieto A, et al. Role of circulating soluble chemokines in septic shock [J]. Med Intensiva, 2013, 37(8): 510-518.
[23]
Roch A, Hraiech S, Dizier S, et al. Pharmacological interventions in acute respiratory distress syndrome [J]. Ann Intensive Care, 2013, 3(1): 20.
[24]
Thompson BT. Corticosteroids for ARDS [J]. Minerva Anestesiol, 2010, 76(6): 441-447.
[25]
Araz O, Demirci E, Yilmazel Ucar E, et al. Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: an experimental study [J]. Multidiscip Respir Med, 2013, 8(1): 74.
[26]
Azoulay É, Canet E, Raffoux E, et al. Dexamethasone in patients with acute lung injury from acute monocytic leukaemia [J]. Eur Respir J, 2012, 39(3): 648-653.
[27]
Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome [J]. N Engl J Med, 2006, 354(16): 1671-1684.
[28]
Annane D, Sébille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome [J]. Crit Care Med, 2006, 34(1): 22-30.
[29]
Peter JV, John P, Graham PL, et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis [J]. BMJ, 2008, 336(7651): 1006-1009.
[30]
付国强,曹义战,仲月霞, 等. 血必净注射液对急性百草枯中毒大鼠肺、血浆TNF-α和IL-10的影响 [J]. 中华急诊医学杂志, 2013, 22(11): 1226-1228.
[31]
周厚荣,张谦,郭军, 等. 血必净对急性呼吸窘迫综合征大鼠炎性因子及肺气-血屏障变化的影响 [J]. 中华急诊医学杂志, 2011, 20(10): 1071-1074.
[32]
陈云霞,李春盛. 血必净治疗脓毒症的随机对照多中心临床研究 [J]. 中华急诊医学杂志, 2013, 22(2): 130-135.
[33]
赵森伟,柴艳芬. 血必净与低分子肝素对严重脓毒症患者凝血功能及预后的影响 [J]. 中华急诊医学杂志, 2011, 20(4): 405-408.
[1] 李文金, 薛庆云. 白细胞介素家族炎性细胞因子在骨关节炎中的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(03): 348-353.
[2] 陈腊青, 林佳佳, 毛洪刚, 童冠海, 汪梦娜, 夏红波, 刘卓, 徐海霞, 赵玉华, 张传领. 血清细胞因子及呼出气一氧化氮在哮喘-慢性阻塞性肺疾病重叠综合征中的临床意义[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 316-320.
[3] 张巧梅, 孙小平, 李冠胜, 邓扬嘉. 针灸对大鼠呼吸机相关性肺炎中性粒细胞归巢及胞外诱捕网的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 265-271.
[4] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[5] 靳茜雅, 黄晓松, 谭诚, 蒋琴, 侯昉, 李瑶悦, 徐冰, 贾红慧, 刘文英. 产前他克莫司治疗对先天性膈疝大鼠病理模型肺血管重构的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 428-436.
[6] 李永浩, 高雪菲, 郭田田, 张进, 张彩针, 刘静. 肥胖合并甲状腺癌相关机制的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 311-315.
[7] 魏强, 张明祥, 陈强谱, 孙宝房. 增味小承气汤对梗阻性黄疸大鼠胃肠道动力的影响[J]. 中华普通外科学文献(电子版), 2023, 17(04): 267-270.
[8] 熊欢庆, 李玉娟, 陈键, 刘刚, 李志超, 金发光. 丹参酮IIA及苦参碱组方对脂多糖致小鼠急性肺损伤的协同保护作用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 455-459.
[9] 沃吟晴, 杨向群. 心脏巨噬细胞的生理功能及在心肌梗死后的作用[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 167-171.
[10] 杨蕴钊, 周诚, 石美涵, 赵静, 白雪源. 人羊水间充质干细胞对膜性肾病大鼠的治疗作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 181-186.
[11] 陈蕊, 杨洪娜, 方巍, 李鑫鑫, 李甜甜, 于孝义, 王艳雪, 李文玉. 血清与支气管肺泡灌洗液中细胞因子水平与肺内外ARDS的相关性研究[J]. 中华重症医学电子杂志, 2023, 09(03): 251-258.
[12] 萨仁高娃, 张英霞, 邓伟, 闫诺, 樊宁. 超声引导下鼠肝消融术后组织病理特征的变化规律及影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 394-398.
[13] 王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
[14] 刘立业, 赵德芳. 非酒精性脂肪肝患者血清细胞因子信号转导抑制因子3、肝X受体α水平与CT影像学特征的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 211-215.
[15] 戚晓阳, 杨平, 杜忠秋, 邱旭升, 汤黎明, 陈一心. 袖状胃切除术对肥胖合并2型糖尿病大鼠模型骨密度的影响[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 102-108.
阅读次数
全文


摘要